Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan

MW Petersen, TS Meyhoff, M Helleberg… - Acta …, 2020 - Wiley Online Library
Introduction Severe acute respiratory syndrome coronavirus‐2 has caused a pandemic of
coronavirus disease (COVID‐19) with many patients developing hypoxic respiratory failure …

[HTML][HTML] Association of corticosteroids use and outcomes in COVID-19 patients: a systematic review and meta-analysis

H Tlayjeh, OH Mhish, MA Enani, A Alruwaili… - Journal of Infection and …, 2020 - Elsevier
Background To systematically review the literature about the association between systemic
corticosteroid therapy (CST) and outcomes of COVID-19 patients. Methods We searched …

[HTML][HTML] Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials

S Ma, C Xu, S Liu, X Sun, R Li, M Mao, S Feng… - Signal transduction and …, 2021 - nature.com
The benefits and harms of corticosteroids for patients with severe coronavirus disease 2019
(COVID-19) remain unclear. We systematically searched PubMed, Embase, and Cochrane …

[HTML][HTML] Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study

Y Shionoya, T Taniguchi, H Kasai, N Sakuma, S Imai… - PLoS …, 2021 - journals.plos.org
Introduction Coronavirus disease (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2. Although most patients with COVID-19 develop asymptomatic or …

[HTML][HTML] Impact of late administration of corticosteroids in COVID-19 ARDS

N Mongardon, M Piagnerelli, D Grimaldi, B Perrot… - Intensive care …, 2021 - Springer
Dear Editor, Acute respiratory distress syndrome (ARDS) related to coronavirus disease
2019 (COVID-19) is challenging. As pro-inflammatory patterns and cytokine storm are …

[HTML][HTML] Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized …

K Ranjbar, M Moghadami, A Mirahmadizadeh… - BMC infectious …, 2021 - Springer
Background Although almost a year has passed since the Coronavirus disease 2019
(COVID-19) outbreak and promising reports of vaccines have been presented, we still have …

Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis

SS Hasan, T Capstick, R Ahmed, CS Kow… - Expert review of …, 2020 - Taylor & Francis
Objectives The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis
is one of the main causes of high mortality in patients with COVID-19 (novel coronavirus …

[HTML][HTML] Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study

JP Kevorkian, JP Riveline, C Vandiedonck… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS), a life-threatening complication of coronavirus
disease-2019 (COVID-19) is associated with elevated risk of intensive care unit (ICU) …

Effectiveness of corticosteroids to treat severe COVID-19: a systematic review and meta-analysis of prospective studies

H Li, B Yan, R Gao, J Ren, J Yang - International Immunopharmacology, 2021 - Elsevier
Objectives To assess the effects of corticosteroid therapy for patients with severe
coronavirus disease 2019 (COVID-19). Methods We comprehensively searched articles …

[HTML][HTML] Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019

J Villar, M Confalonieri, SM Pastores… - Critical care …, 2020 - journals.lww.com
In December 2019, pneumonia associated with the novel coronavirus disease 2019 (COVID-
19) emerged in Wuhan, China. On March 14, 2020, the World Health Organization (WHO) …